Literature DB >> 21175674

The coming of age of antibiotics: discovery and therapeutic value.

Karen Bush1.   

Abstract

Origins of antibiotic drug discovery are frequently traced to 1929 when Alexander Fleming recognized the antibacterial activity of a substance secreted by Penicillium notatum on a contaminated culture plate. However, the subsequent development of penicillin as a therapeutic agent was not realized until the early 1940s, after a consortium of academic and pharmaceutical scientists from England and the United States developed sufficiently advanced fermentation technology to produce high-purity penicillin in large enough quantities for medical supplies. It was at this time that the antibiotic era was truly successfully launched. During the following decade, unprecedented antibiotic research and development emerged in academic laboratories and the pharmaceutical industry, resulting in identification of most of the antibiotic classes currently used therapeutically. This short historical commentary describes some of these early events, beginning with a conference held at the New York Academy of Sciences in 1946, the first conference to focus entirely on the latest science related to the identification and characterization of antibacterial substances produced by microorganisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21175674     DOI: 10.1111/j.1749-6632.2010.05872.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.

Authors:  S D Lahiri; M R Johnstone; P L Ross; R E McLaughlin; N B Olivier; R A Alm
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

2.  Combatting Spanish influenza: Focus on pharmacists, pharmacies and drugs.

Authors:  Mary E MacCara
Journal:  Can Pharm J (Ott)       Date:  2020-10-17

3.  Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases.

Authors:  Sushmita D Lahiri; Stefano Mangani; Thomas Durand-Reville; Manuela Benvenuti; Filomena De Luca; Gautam Sanyal; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

Review 4.  Metallo-β-lactamase structure and function.

Authors:  Timothy Palzkill
Journal:  Ann N Y Acad Sci       Date:  2012-11-16       Impact factor: 5.691

5.  Extracellular probiotic lipase capped silver nanoparticles as highly efficient broad spectrum antimicrobial agents.

Authors:  Imran Khan; Nivetha Sivasankaran; Ravikiran Nagarjuna; Ramakrishnan Ganesan; Jayati Ray Dutta
Journal:  RSC Adv       Date:  2018-09-06       Impact factor: 4.036

Review 6.  Diversity, Ecology, and Prevalence of Antimicrobials in Nature.

Authors:  Megan M Mullis; Ian M Rambo; Brett J Baker; Brandi Kiel Reese
Journal:  Front Microbiol       Date:  2019-11-14       Impact factor: 5.640

7.  Peptidoglycan: a post-genomic analysis.

Authors:  Caroline Cayrou; Bernard Henrissat; Philippe Gouret; Pierre Pontarotti; Michel Drancourt
Journal:  BMC Microbiol       Date:  2012-12-18       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.